These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 20696092)

  • 1. Drug disposition in obesity and protein-energy malnutrition.
    Boullata JI
    Proc Nutr Soc; 2010 Nov; 69(4):543-50. PubMed ID: 20696092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial dosing considerations in obese adult patients.
    Pai MP; Bearden DT
    Pharmacotherapy; 2007 Aug; 27(8):1081-91. PubMed ID: 17655508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosing dilemmas in obese children.
    Mulla H; Johnson TN
    Arch Dis Child Educ Pract Ed; 2010 Aug; 95(4):112-7. PubMed ID: 20585055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review.
    Polso AK; Lassiter JL; Nagel JL
    J Clin Pharm Ther; 2014 Dec; 39(6):584-608. PubMed ID: 25203631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of obesity on the pharmacokinetics of drugs in humans.
    Hanley MJ; Abernethy DR; Greenblatt DJ
    Clin Pharmacokinet; 2010; 49(2):71-87. PubMed ID: 20067334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
    Pai MP
    Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.
    Natale S; Bradley J; Nguyen WH; Tran T; Ny P; La K; Vivian E; Le J
    Pharmacotherapy; 2017 Mar; 37(3):361-378. PubMed ID: 28079262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexplained disturbance in body weight regulation: diagnostic outcome assessed by doubly labeled water and body composition analyses in obese patients reporting low energy intakes.
    Buhl KM; Gallagher D; Hoy K; Matthews DE; Heymsfield SB
    J Am Diet Assoc; 1995 Dec; 95(12):1393-400; quiz 1401-2. PubMed ID: 7594141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body composition and energy expenditure: relationship and changes in obese subjects before and after biliopancreatic diversion.
    Tacchino RM; Mancini A; Perrelli M; Bianchi A; Giampietro A; Milardi D; Vezzosi C; Sacco E; De Marinis L
    Metabolism; 2003 May; 52(5):552-8. PubMed ID: 12759883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hunger disease.
    Elia M
    Clin Nutr; 2000 Dec; 19(6):379-86. PubMed ID: 11104587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in energy expenditure resulting from altered body weight.
    Leibel RL; Rosenbaum M; Hirsch J
    N Engl J Med; 1995 Mar; 332(10):621-8. PubMed ID: 7632212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of obesity on drug pharmacokinetics in humans.
    Morrish GA; Pai MP; Green B
    Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):697-706. PubMed ID: 21417960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of catch-up growth after early malnutrition for the programming of obesity in male rat.
    Bieswal F; Ahn MT; Reusens B; Holvoet P; Raes M; Rees WD; Remacle C
    Obesity (Silver Spring); 2006 Aug; 14(8):1330-43. PubMed ID: 16988075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline disposition in obese rats.
    Shum L; Jusko WJ
    J Pharmacol Exp Ther; 1984 Feb; 228(2):380-6. PubMed ID: 6694116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of obesity on drug disposition.
    Blouin RA; Kolpek JH; Mann HJ
    Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of intradialytic parenteral nutrition to treat malnutrition: a case study.
    Wong P; Smith P; Rodger D
    CANNT J; 2003; 13(2):31-46; quiz 37-9,46-8. PubMed ID: 14535227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition phenotypes in pathways to obesity and the metabolic syndrome.
    Dulloo AG; Jacquet J; Solinas G; Montani JP; Schutz Y
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S4-17. PubMed ID: 21151146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of endurance exercise with and without a reduction of energy intake on fat-free mass and the composition of fat-free mass in obese women.
    Van Loan MD; Keim NL; Barbieri TF; Mayclin PL
    Eur J Clin Nutr; 1994 Jun; 48(6):408-15. PubMed ID: 7925223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.